Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)

This document (A59659) is a response-to-comments record for the Implantable Continuous Glucose Monitors (I-CGM) policy L38623, summarizing that the public comment period ran from 2023-10-05 to 2023-11-18 and that submitted comments were reviewed and addressed. It does not itself state clinical coverage indications, limitations, or frequency limits; refer to policy L38623 for the formal coverage criteria.

"Public comment period for Implantable Continuous Glucose Monitors (I-CGM) L38623 ran 2023-10-05 to 2023-11-18; comments were received and reviewed and grouped by topic with responses provided."

Sign up to see full coverage criteria, indications, and limitations.